| 3945 |
Procedure of Quality Control |
Live |
21/11/2022 |
| 3943 |
MGIT DST Quality Control |
Live |
21/11/2022 |
| 3944 |
Standard Controls |
Live |
21/11/2022 |
| 3942 |
Retesting MGIT DST Results |
Live |
21/11/2022 |
| 3941 |
Troubleshooting Unexpected/False Profile of DST Isolates |
Live |
21/11/2022 |
| 3940 |
Troubleshooting False Resistant DST Results |
Live |
21/11/2022 |
| 3939 |
Troubleshooting False Susceptible DST Results |
Live |
21/11/2022 |
| 3938 |
Troubleshooting Non-interpretable DST Results |
Live |
21/11/2022 |
| 3937 |
Troublsehooting Invalid DST Sets " X" |
Live |
21/11/2022 |
| 3936 |
MGIT 960 DST Inoculum Troubleshooting |
Live |
21/11/2022 |
| 3935 |
MGIT 960 DST Equipment and Reagents Troubleshooting |
Live |
21/11/2022 |
| 3934 |
Final Result Reporting |
Live |
21/11/2022 |
| 3933 |
Drug Susceptibility Testing Logs |
Live |
21/11/2022 |
| 3931 |
LC DST Recording and Reporting |
Live |
21/11/2022 |
| 3930 |
Validation of Resistant/Unexpected MGIT DST Results |
Live |
21/11/2022 |
| 3929 |
Unloaded MGIT DST Report |
Live |
21/11/2022 |
| 3928 |
Procedure for Reading MGIT DST Results |
Live |
21/11/2022 |
| 3927 |
Principle of MGIT DST Reading |
Live |
21/11/2022 |
| 3924 |
PZA Inoculum Preparation |
Live |
21/11/2022 |
| 3925 |
Inoculation of PZA Growth Control/Drug Containing Tube |
Live |
21/11/2022 |
| 3926 |
Incubation of MGIT 960 DST Sets |
Live |
21/11/2022 |
| 3923 |
Inoculation of Growth Control Tube/Drug Containing Tubes |
Live |
21/11/2022 |
| 3922 |
Inoculum Preparation from MGIT Positive Culture |
Live |
21/11/2022 |
| 3921 |
Inoculum Preparation for First and Second-line Phenotypic DST |
Live |
21/11/2022 |
| 3920 |
Preparation and Storage of Second-line Anti-TB Drugs used for DST |
Live |
21/11/2022 |
| 3919 |
Critical Concentration and formulations of Second-line Anti-TB Drugs for DST |
Live |
21/11/2022 |
| 3918 |
Second-line Phenotypic Drug Susceptibility Testing |
Live |
21/11/2022 |
| 3917 |
Critical Concentration and Reconstitution of PZA |
Live |
21/11/2022 |
| 3915 |
Critical Concentrations and Reconstitution of SIRE Drugs |
Live |
21/11/2022 |
| 3916 |
Pyrazinamide PZA Susceptibility Testing |
Live |
21/11/2022 |
